Mallinckrodt Pharmaceuticals
Open-Label Expanded Access Treatment Protocol for VTS-270
.
Christopher Hitchens
email: christopher.hitchens@mnk.com | phone: 202-494-0788
Karrie Hilsinger
email: karrie.hilsinger@mnk.com | phone: 908-310-0135
CLINICALTRIALS.GOV LINK
_____________________________
Mallinckrodt Announces an Open-label
Expanded Access Treatment Protocol for VTS-270
.
CLICK HERE FOR COMPLETE ANNOUNCEMENT
08/27/2018 jjb
